Submissions

Guidelines and requirements for preparing and submitting your manuscript.

Login or Register to make a submission.

Author Guidelines

Journal of Cancer Research, Therapy and Perspectives (JCRTP) welcomes original research articles, review articles, systematic reviews, clinical studies, case reports, short communications, and scholarly perspectives related to cancer research, prevention, diagnosis, treatment, therapy, oncology, supportive care, and related disciplines.

Manuscripts should be original, scientifically sound, clearly written in English, and not previously published or simultaneously submitted to another journal. Authors should follow recognized ethical standards for research involving human participants or animals and provide details of ethical approval and informed consent where applicable.

Manuscripts should normally include a title, author information, abstract, keywords, main text, declarations, acknowledgements where applicable, funding information, conflicts of interest, and references. Tables and figures should be clearly numbered and referred to in the text.

Authors are responsible for the accuracy of their work, references, data, authorship information, permissions, and ethical declarations. All eligible contributors should be identified appropriately. Submissions will undergo editorial assessment and suitable manuscripts may proceed to peer review.

Submission Preparation Checklist

Before submitting, please confirm that:

• The manuscript is original and is not under consideration by another journal.
• All authors have reviewed and approved the submission.
• The manuscript falls within the aims and scope of JCRTP.
• Ethical approval and informed consent information are included where applicable.
• Conflicts of interest and funding sources have been disclosed.
• References have been checked for accuracy and consistency.
• Tables, figures and supplementary materials are properly identified.
• Permission has been obtained for copyrighted material used from other sources.
• Author names, affiliations and contact information are accurate.

Section Policies

Original Research Articles

This section publishes original research relevant to cancer research, prevention, diagnosis, treatment, therapy, oncology, supportive care, and related clinical and biomedical disciplines. Submissions should present original findings, follow appropriate research and ethical standards, and will normally undergo peer review before an editorial decision.

 

Review Articles

This section publishes comprehensive and scholarly review articles addressing important topics in cancer research, oncology, prevention, diagnosis, treatment, therapy, supportive care, and related disciplines. Reviews should critically evaluate current evidence, identify important developments and knowledge gaps, and provide scientifically supported conclusions. Submissions will normally undergo peer review.

 

Systematic Reviews and Meta-Analyses

This section publishes systematic reviews and meta-analyses addressing clinically and scientifically relevant questions in cancer research, oncology, prevention, diagnosis, treatment, therapy, and supportive care. Submissions should use a clearly defined research question, transparent search strategy, appropriate eligibility criteria, systematic methods of evidence synthesis, and recognized reporting standards. Submissions will undergo peer review.

 

Case Reports.

This section publishes clinically significant case reports related to cancer diagnosis, treatment, therapy, complications, unusual presentations, rare malignancies, or noteworthy patient outcomes. Submissions should provide clear clinical information, appropriate discussion of the case and its relevance to existing knowledge, and confirmation of patient consent where applicable. Submissions will undergo peer review.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.